ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas V. Bilfinger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilfinger, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilfinger, T. V.
Related Collections
Right arrow Extracorporeal circulation

Ann Thorac Surg 2006;81:2201
© 2006 The Society of Thoracic Surgeons


Original article: Cardiovascular

Invited commentary

Thomas V. Bilfinger, MD, ScD

Department of Surgery, SUNY at Stony Brook, HSC T19 Rm80, Stony Brook, NY 11794

(Email: tbilfinger{at}notes.cc.sunysb.edu).

Hsing and colleagues [1] describe for the first time the kinetics of interleukins belonging to the interleukin (IL)-10 family in conjunction with cardiopulmonary bypass (CPB). There are at least five novel human IL-10 family molecules: IL-19, IL-20, IL-22, IL-24, and IL-26. Similar to IL-10, these are secreted {alpha}-helical proteins with 30% homology in amino-acid sequence and definite positions for cysteine. The encoding genes are located in two clusters: IL-19, 20, 24 on1q31-32; IL-22, 26 on 12q15. In contrast to IL-10 being expressed in monocytes, less in NK cells, B cells and T cells, IL-19 and IL-20 are preferentially expressed in monocytes, and IL-22 is restricted to T cells and NK cells. So far their function is poorly understood, but it seems to be rather pro-inflammatory in distinction to IL-10. Interleukins 19 and 20 are associated with psoriatric skin lesions, while IL-22 has been associated with the acute phase reaction and inflammation and also with neonatal death. No clinical effect of these cytokines after CPB is known so far. Their pro-inflammatory effect seems to be a downstream phenomenon occurring after TNF{alpha}, IL-6, and IL-8 induction. This report from healthy patients serves as a first baseline of "normal" behavior of the expression of these molecules after bypass surgery. As we know, a "normal" pattern of established pro-inflammatory and anti-inflammatory cytokines after CPB has been described. We still have great difficulty to detect abnormal patterns, particularly in advance of a clinical correlate. With this article we have to add three more molecules to the list of inflammatory markers.


    References
 Top
 References
 

  1. Hsing C-H, Hsieh M-Y, Chen W-Y, et al. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 2006;81:2196–2201..




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas V. Bilfinger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilfinger, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilfinger, T. V.
Related Collections
Right arrow Extracorporeal circulation


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS